Clinical-stage ophthalmic company focused on novel therapeutics to address unmet medical needs, providing for the restoration, preservation, and improvement of patient vision and quality of life.
Acquired by a strategic in 2024
Amber Ophthalmics
Status: Prior Investments
Eyevance Pharmaceuticals
Commercial-stage specialty ophthalmic company focused on innovative and impactful branded prescription products targeting the anterior segment of the eye.
Acquired by Santen in 2020
Recent Comments